- €2.42bn
- €2.39bn
- €751.45m
- 76
- 27
- 16
- 30
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 375 | 446 | 501 | 618 | 751 |
Cost of Revenue | |||||
Gross Profit | 112 | 133 | 126 | 152 | 174 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 298 | 384 | 452 | 589 | 725 |
Operating Profit | 77.5 | 62.6 | 48.6 | 29.1 | 26.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 72 | 56.6 | 25.8 | 237 | -154 |
Provision for Income Taxes | |||||
Net Income After Taxes | 84.1 | 37.2 | 6.28 | 216 | -176 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 84.2 | 38.1 | 6.28 | 216 | -176 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 84.2 | 38.1 | 6.28 | 216 | -176 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.522 | 0.307 | 0.055 | 1.36 | -1.02 |
Dividends per Share |